NCT04419077View on ClinicalTrials.gov

Interest of Virtual Reality to Prevent Cancer Patient Anxiety Before Chemotherapy or an Invasive Act

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

June 7, 2020

Primary Completion Date

June 16, 2022

Study Completion Date

June 16, 2022

Conditions
AnxietyChemotherapy EffectBreast CancerHead Cancer Neck
Interventions
BEHAVIORAL

Virtual reality exposure

"Patients will be exposed to a 10-20 min virtual reality session just before an oncological procedure (invasive act or chemotherapy).~Patients will be able to choose between 4 virtual universes (beach, underwater, forest, space) and seven musical content."

Trial Locations (1)

69495

Service d'oncologie médicale, Institut de Cancérologie des Hospices Civils de Lyon, Hôpital Lyon sud, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04419077 - Interest of Virtual Reality to Prevent Cancer Patient Anxiety Before Chemotherapy or an Invasive Act | Biotech Hunter | Biotech Hunter